Chronic kidney disease (CKD)-related anaemia is a common and debilitating complication, primarily due to a relative deficiency ...

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Researchers at the University of Pittsburgh have identified a new way of predicting whether a kidney donor and recipient are ...

Earlier use of combination therapies is purported to improve outcomes in many disease states, including lupus nephritis.

Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, ...

A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...